One Antiplatelet Drug After Heart Valve ReplacementWorks as Well as Two, with Fewer Complications
Loyola MedicineTreatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A Loyola Medicine study has found that a single antiplatelet drug may work just as well, with lower risks of life-threatening bleeding and other complications.